[Aprospos of coexisting pancreatic disease in patients with chronic hepatitis and post-hepatitis liver cirrhosis. Value of the combined pancreozymin and secretin test].
作者信息
Areşteanu L, Nicolau S, Rubingher L, Andreiaş C, Dulceanu I
出版信息
Med Interna (Bucur). 1965 Sep;17(9):1111-8.
PMID:5843760
Abstract
摘要
相似文献
1
2
[Value of the double secretin-pancreozymin test in the biological diagnosis of pancreatic diseases].[双倍促胰液素-胰酶泌素试验在胰腺疾病生物学诊断中的价值]
Acta Gastroenterol Belg. 1966 Feb;29(2):173-8.
3
[Initial results of fluorescence (tetracycline) tests during the double secretin-pancreozymin test].
Acta Gastroenterol Belg. 1966 Feb;29(2):179-82.
4
[Pancreatic function after secretin-pancreozymin stimulation in diseases of various types].[不同类型疾病中促胰液素-胰酶泌素刺激后的胰腺功能]
Atti Accad Fisiocrit Siena Med Fis. 1964;13(2):972-8.
5
[Changes of excretory pancreatic function in patients with liver cirrhosis and chronic hepatitis].[肝硬化和慢性肝炎患者胰腺排泄功能的变化]
Dtsch Z Verdau Stoffwechselkr. 1976;36(5-6):269-74.
6
[Excretory pancreatic function in liver cirrhosis and chronic hepatitis].[肝硬化和慢性肝炎患者的胰腺排泄功能]
Dtsch Z Verdau Stoffwechselkr. 1976;36(5-6):275-80.
7
8
9
Serum esterolytic activity in a wide variety of diseases. With special reference to pancreatic and liver disease.
N Engl J Med. 1966 Jan 20;274(3):129-33. doi: 10.1056/NEJM196601202740302.
10
Inhibition of gastric motility by a commercial duodenal mucosal extract containing cholecystokinin and pancreozymin.含胆囊收缩素和促胰酶素的市售十二指肠黏膜提取物对胃动力的抑制作用。
Nature. 1965 Sep 25;207(5004):1401. doi: 10.1038/2071401a0.
Zotero 插件